Mannatech Receives Additional Certifications from NSF International
COPPELL, Texas--([ BUSINESS WIRE ])--Mannatech, Incorporated (NASDAQ:MTEX), a leading developer and provider of proprietary dietary supplements, weight management products and skin care solutions, today announced its [ PhytoMatrix ]® multivitamin/mineral supplement and [ Optimal Support Packets ] have been added to the list of certified products by [ NSF International ], an independent and accredited testing laboratory. To date, Mannatech has received certifications from NSF for its core products of PhytoMatrix® caplets, PLUS™ caplets, Ambrotose AO® capsules and Advanced Ambrotose® powder and capsules. The company has also received NSF certification for its Ambrotose® complex powder and capsules.
NSF evaluated the PhytoMatrix® caplets and Optimal Support Packets, which were certified according to the NSF/ANSI 173 Dietary Supplement Standard—the only American National Standard for dietary supplements. [ Mannatech ] intends to carry the NSF certification mark on the supplements' labels and promotional materials to demonstrate compliance.
"We strive to ensure all of our products meet the strictest guidelines for purity, and these additional certifications from NSF exemplify our commitment to offering our customers the highest quality. In addition to these certifications, we ensure that all our manufacturing partners adhere to the Good Manufacturing Practices, the regulatory guidelines for dietary supplement manufacturing," said Marika Berkley, vice president of global regulatory affairs and quality assurance for Mannatech. "We will continue to seek NSF certification on our entire product line so customers know they are receiving ultimate value and quality when purchasing and consuming Mannatech products."
NSF International—a not-for-profit public health certification organization—ensures a product's label reflects the contents of the supplement, that all ingredients are openly disclosed on the label and that the product's purity is acceptable. Additionally, NSF assesses each manufacturing site to ensure it complies with Good Manufacturing Practices; NSF will not certify a product unless the manufacturer meets these rigorous audits.
To date, all Mannatech products submitted to NSF have received product certification. Mannatech will continue working with NSF to certify additional products.
About Mannatech
Mannatech, Incorporated, is a global wellness solutions provider of innovative, high-quality, proprietary dietary supplements, skin care products, and weight management products sold through independent Associates and Members located in the United States and the international markets of Canada, Australia, the United Kingdom, Japan, New Zealand, the Republic of Korea, Taiwan, Denmark, Germany, South Africa, and Singapore. For more information please visit [ www.mannatech.com ] or [ www.allaboutmannatech.com ].
Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech's inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.